Announced
Completed
Financials
Tags
DNA-Encoded Library
Biotechnology
discovery services
Private
Single Bidder
United States
Friendly
Acquisition
Private Equity
Majority
Completed
Disposal
Cross Border
Synopsis
GHO Capital, a specialist healthcare investment advisor, completed the acquisition of X-Chem, a biotechnology company, from Hellman & Friedman and The Carlyle Group. Financial terms were not disclosed. “We are delighted to have the opportunity to work with the X-Chem team. With its proven DEX discovery platform, X-Chem is the go-to provider for small molecule drug discovery for all of biopharma and poised for future growth,” GHO Capital.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.